Title |
Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
|
---|---|
Published in |
Therapeutics and Clinical Risk Management, November 2021
|
DOI | 10.2147/tcrm.s303057 |
Pubmed ID | |
Authors |
Honeylen Maryl Teo, Terry J Smith, Shannon S Joseph |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 11 | 58% |
Librarian | 1 | 5% |
Student > Bachelor | 1 | 5% |
Researcher | 1 | 5% |
Student > Doctoral Student | 1 | 5% |
Other | 1 | 5% |
Unknown | 3 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 10 | 53% |
Medicine and Dentistry | 2 | 11% |
Agricultural and Biological Sciences | 1 | 5% |
Business, Management and Accounting | 1 | 5% |
Neuroscience | 1 | 5% |
Other | 1 | 5% |
Unknown | 3 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2022.
All research outputs
#4,242,890
of 23,098,660 outputs
Outputs from Therapeutics and Clinical Risk Management
#200
of 1,274 outputs
Outputs of similar age
#95,090
of 438,440 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 13 outputs
Altmetric has tracked 23,098,660 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,274 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,440 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.